30 October 2025 · 1 min read
Two panels, one question: Are we ready for healthcare's AI decade?
At the Global Health Exhibition in Riyadh, I moderated two panels bringing together top investors and operators to explore how AI can move from pilot to platform across pharma and care delivery — and the consensus was clear: execution, not technology, will define the winners of the next wave of digital health.
Filed under GCC Health Tech · AI in Pharma
Two panels, one question: Are we ready for healthcare's AI decade?
At the Global Health Exhibition - ملتقى الصحة العالمي in Riyadh, I had the privilege of joining (and moderating) two panels at the Global Health Exhibition Riyadh, bringing together top investors and operators to dissect how AI can move from pilot to platform across pharma and care delivery.
From venture capital to workflow integration, the consensus was clear: execution will define the winners of the next wave of digital health. The hard part in AI isn't the technology, but the careful focus on bringing the people with you if you truly want to deploy AI at scale.
The technology is ready for large scale admin improvements, and reshaping the way we discover and develop drugs, but our organisations, from large health care providers to big corporates, often struggle to bring their teams along in the journey.
The key insight: We're not in an AI bubble, we're in a fundamental learning curve.
Rana Lonnen, Christian Lautner, Rishad Usmani, MD, Natasha Naidoo, Stuart McGoldrick, Michael Brenden Davis, Antoine D'Hollander
Related insights
6 Nov 2025
After working with both global pharma leaders and early-stage AI firms, I've seen a pattern: Par...
29 Jan 2025
A really insightful panel discussion on longevity at WHX Dubai (formerly Arab Health), hosted b...
17 Mar 2026
Roche’s hybrid-cloud AI factory: why adoption matters more than GPUs
10 Mar 2026
AI drug discovery benchmarks: why pharma needs model evaluation discipline